Form 4: Adaptive Biotechnologies Officer Sells Shares

Adaptive Biotechnologies' Chief People Officer, Francis Lo, sold 30,593 shares of common stock under a pre-arranged trading plan.

Summary

• Francis Lo, Chief People Officer of Adaptive Biotechnologies Corp. (ADPT), disposed of 30,593 shares of common stock.
• The transaction occurred on March 11, 2026, at a weighted average price of $14.08 per share.
• Shares were sold in multiple transactions ranging from $13.81 to $14.38.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2025.
• Following the transaction, Francis Lo directly beneficially owns 291,374 shares of common stock.
• An additional 2,500 shares are indirectly beneficially owned by You Jin Lee (spouse).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically does not carry significant positive or negative implications for the company's fundamentals.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a lack of confidence, though this is often not the case for routine sales.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 trading plan, are a common practice for executives to manage personal finances, diversify holdings, or exercise stock options. Such transactions are typically pre-scheduled and do not necessarily reflect a change in the company's operational performance or future prospects.

Related Party Transactions

• Francis Lo indirectly beneficially owns 2,500 shares through his spouse, You Jin Lee.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine insider transaction under a pre-arranged plan, not indicative of a change in company fundamentals.
• Reporting Person: Reduction in direct beneficial ownership of company stock.

Key Dates

Recommendation

This Form 4 reports a pre-scheduled insider sale by the Chief People Officer, which is a common practice for executive compensation and personal financial management. Such a transaction, particularly when executed under a Rule 10b5-1 plan, typically does not indicate a change in the company's fundamental outlook and therefore does not warrant a change in investment recommendation based solely on this filing.

Keywords

Adaptive Biotechnologies, ADPT, Insider Trading, Form 4, Stock Sale, Francis Lo, Chief People Officer, 10b5-1 Plan